Camtek director sells 6,694 shares of stock

Camtek Ltd (CAMT) director Aviram Lior reported selling a total of 6,694 ordinary shares in four open-market transactions on August 11–12, 2026, at prices between 162.0000 and 175.0000 per share.

Rhea-AI Filing Summary

Camtek Ltd (CAMT) director Aviram Lior reported selling a total of 6,694 ordinary shares in four open-market transactions on August 11–12, 2026, at prices between 162.0000 and 175.0000 per share. The Rule 10b5-1 checkbox was not selected. A footnote explains that one additional share had been omitted from a prior Form 3 due to a rounding error.

Insider Trade Summary

Net Seller: 6,694 shares

Net Sell 4 txns

Insider Aviram Lior

Role Director

Sold 6,694 shs ($1.13M)

Type	Security	Shares	Price	Value
Sale	Ordinary Shares	1,666	$172.73	$288K
Sale	Ordinary Shares	1,681	$175.00	$294K
Sale	Ordinary Shares F1	1,658	$164.00	$272K
Sale	Ordinary Shares	1,689	$162.00	$274K

Holdings After Transaction: Ordinary Shares — 12,518 shares (Direct)

Footnotes (1)

1. F1. The reported balance includes one additional share that was inadvertently omitted from the reporting person's Form 3 due to a rounding error.

Key Figures

Total shares sold: 6,694 shares Shares sold on 2026-08-12 at 172.7300: 1,666 shares Shares sold on 2026-08-12 at 175.0000: 1,681 shares +4 more

7 metrics

Total shares sold 6,694 shares Aggregate ordinary shares sold across four transactions on August 11–12, 2026

Shares sold on 2026-08-12 at 172.7300 1,666 shares Ordinary shares sold on August 12, 2026 at 172.7300 per share

Shares sold on 2026-08-12 at 175.0000 1,681 shares Ordinary shares sold on August 12, 2026 at 175.0000 per share

Shares sold on 2026-08-11 at 164.0000 1,658 shares Ordinary shares sold on August 11, 2026 at 164.0000 per share

Shares sold on 2026-08-11 at 162.0000 1,689 shares Ordinary shares sold on August 11, 2026 at 162.0000 per share

Rule 10b5-1 checkbox false Document-level Rule 10b5-1(c) checkbox was not selected

Footnote correction 1 share Additional share noted due to prior Form 3 rounding error in footnote F1

Key Terms

Form 3, rounding error, Ordinary Shares, Rule 10b5-1

4 terms

Form 3 regulatory

"omitted from the reporting person's Form 3 due to a rounding error"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

rounding error financial

"one additional share that was inadvertently omitted ... due to a rounding error"

Ordinary Shares financial

"security_title: Ordinary Shares in each reported transaction"

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

Rule 10b5-1 regulatory

"The document-level Rule 10b5-1 checkbox was not selected"

Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Aviram Lior report for CAMT on this Form 4?

Director Aviram Lior reported selling 6,694 ordinary shares of Camtek Ltd in four open-market transactions on August 11–12, 2026. All transactions involved non-derivative ordinary shares held directly.

How many Camtek (CAMT) shares did Aviram Lior sell and on which dates?

Aviram Lior sold 6,694 ordinary shares of Camtek Ltd across four transactions on August 11 and 12, 2026. Each transaction involved a separate block of shares at different per-share prices.

At what prices were the CAMT shares sold in Aviram Lior’s Form 4?

The reported sales were executed at per-share prices of 162.0000, 164.0000, 172.7300, and 175.0000. These trades together reflect a price range from 162.0000 to 175.0000 per ordinary share.

Was Aviram Lior’s CAMT Form 4 filed under a Rule 10b5-1 trading plan?

The document-level Rule 10b5-1 checkbox was not selected, and there is no footnote stating the trades were made under a Rule 10b5-1 trading plan. The timing is therefore not identified as plan-based in this filing.

What does footnote F1 mean in Aviram Lior’s Camtek (CAMT) Form 4?

Footnote F1 states that the reported balance includes one additional share that was inadvertently omitted from Aviram Lior’s prior Form 3 due to a rounding error. It clarifies historical ownership reporting rather than the sale mechanics.

Does Aviram Lior’s CAMT Form 4 report any derivative securities transactions?

No derivative securities transactions are reported. All four entries involve non-derivative ordinary shares, and the derivative positions section shows no derivative transactions in this filing’s summary data.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/13/2026 - 10:41 AM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Aviram Lior

(Last) (First) (Middle)

HOFAIN

(Street)

TEL AVIV 00000

(City) (State) (Zip)

ISRAEL

(Country)

2. Issuer Name and Ticker or Trading Symbol
CAMTEK LTD [ CAMT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/11/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	08/11/2026		S		1,658	D	$164	17,554(1)	D
Ordinary Shares	08/11/2026		S		1,689	D	$162	15,865	D
Ordinary Shares	08/12/2026		S		1,666	D	$172.73	14,199	D
Ordinary Shares	08/12/2026		S		1,681	D	$175	12,518	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The reported balance includes one additional share that was inadvertently omitted from the reporting person's Form 3 due to a rounding error.

	/s/ Meirav Shemesh on behalf of Oppenheimer Israel, as Attorney-in-fact	08/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)